Brendan J. Keating
Chief Accounting Officer & ControllerMr. Brendan J. Keating, Ph.D, has been Chief Accounting Officer and Controller at FTI Consulting, Inc. since March 18, 2019. Mr. Keating served as Vice President and Assistant Controller at FTI Consulting, Inc. since September 2011 until March 18, 2019. Mr. Keating has experience in the finance and accounting fields, including SEC registration and reporting, accounting policy, international accounting operations, consolidation, internal controls and compliance. Prior to joining FTI Consulting in 2011, Mr. Keating served as Senior Vice President of Accounting Policy and Reporting at Discovery, Inc., from 2008 to 2011 where he led Discovery’s SEC registration and the implementation of internal controls over financial reporting to become compliant with the Sarbanes-Oxley Act of 2002. His previous experience includes serving as Vice President and Assistant Controller at The AES Corporation. Mr. Keating began his career at Coopers & Lybrand, now part of PricewaterhouseCoopers, where he served as a Manager in the Audit practice, serving clients in the high technology, government contracting and real estate industries. He served as Senior Vice President, Chief Accounting Officer and Corporate Controller of MeriStar Hospitality Corporation at MeriStar Hospitality Operating Partnership, L.P. and Meristar Hospitality Finance Corp. since May 2003. Mr. Keating served as Senior Vice President, Chief Accounting Officer and Corporate Controller of Meristar Hospitality Finance Corp. III since May 2003. He is Scientific Founder of Identitas, Inc. He served as Member of Scientific Advisory Board of Identitas, Inc. Prior to joining MeriStar Hospitality, Mr. Keating served in various capacities at LCI International, Inc., until its acquisition by Qwest in June 1998, when Mr. Keating became Assistant Controller-International of Qwest. While at Qwest, Mr. Keating played a significant role in establishing the Netherlands based joint venture between Qwest and KPN Telecom, KPNQwest, N.V., where he was later named Senior Vice President-Finance. Prior to his eight years of experience in the telecommunications industry, Mr. Keating's initial training in molecular biology and molecular genetics led him to focus on asssesing the functional impact of genetic variants, particularly single nucleotide polymorphisms (SNPs) on human disease. In commercial biotechnology, his research included genetically characterized human tissues, in Genaissance (now Clinical Data). He has a broad spectrum of interests in genomics where he has applied new technologies and genetic knowledge to large problems by developing a number of genomic tools which have been commercialized by HaploChIP (Sequenom) and the HumanCVD BeadChip series (Illumina). He completed his post-doctoral fellowship at the Institute of Translational Medicine at the University of Pennsylvania.He received his D.Phil (Ph.D.) from Christ Church College, University of Oxford, with his lab work conducted within the Wellcome Trust Center for Human Genetics with the Clinical Medicine Division.
Positions
- Company NameFTI Consulting, Inc.Stock CodeFCNPositionChief Accounting Officer & ControllerColleagues
- SHSteven H. GunbyPresident, CEO & Chairman
- PLPey-Lin LuGeneral Counsel
- PAPaul Alderman LintonChief Strategy and Transformation Officer
- ENEun NamChief Financial Officer
- OPOliver PawleChairman of European Advisory Board
- NCNicholas C. FanandakisIndependent Director
- LELaureen E. SeegerIndependent Director
- SCStephen C. RobinsonIndependent Director
